Shire Subpoenaed In U.S. Drug Marketing Probe

Date : 10/30/2009 @ 8:51AM
Source : Dow Jones News
Stock : Shire (SHP)
Quote : 1181.0  -7.0 (-0.59%) @ 9:14AM
<< BackQuote Chart

 



Shire Subpoenaed In U.S. Drug Marketing Probe

   By Jason Douglas 
   Of DOW JONES NEWSWIRES 
 

LONDON -(Dow Jones)- U.K. drug maker Shire PLC (SHP.LN) said Friday it has been subpoenaed by the U.S. authorities over the marketing of three bestselling drugs.

Shire said it received a subpoena Sept. 23 from the U.S. Department of Health and Human Services Office of Inspector General in coordination with the U.S. Attorney for the Eastern District of Pennsylvania, seeking production of documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse.

Shire is cooperating and responding to this subpoena, it said.

Company Web site: www.shire.com

-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272; jason.douglas@dowjones.com

 
 

<< Back


Shire Historical Chart Shire Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
32 site:2us 091126 09:29 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )